These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10874052)

  • 61. Respiratory system involvement in antineutrophil cytoplasmic-associated systemic vasculitides: clinical, pathological, radiological and therapeutic considerations.
    Pesci A; Manganelli P
    Drugs R D; 2007; 8(1):25-42. PubMed ID: 17249847
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
    Jordan SC; Toyoda M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term follow-up of relapsing/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H).
    Walsh M; Chaudhry A; Jayne D
    Ann Rheum Dis; 2008 Sep; 67(9):1322-7. PubMed ID: 18055469
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Primary systemic vasculitis.
    Day C; Savage C
    Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ANCA-associated vasculitis: new options beyond steroids and cytotoxic drugs.
    Selamet U; Kovaliv YB; Savage CO; Harper L
    Expert Opin Investig Drugs; 2007 May; 16(5):689-703. PubMed ID: 17461741
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
    Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
    Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antineutrophil cytoplasmic antibodies (ANCA) and small vessel vasculitis.
    Mareen P; Van De Walle S; Bernaert P; Vanhouteghem H; Dierick J
    Acta Clin Belg; 2003; 58(3):193-200. PubMed ID: 12945480
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of anti-neutrophil cytoplasmic antibody assay to distinguish between vasculitic disease activity and complications of cytotoxic therapy.
    Markey BA; Warren JS
    Am J Clin Pathol; 1994 Nov; 102(5):589-94. PubMed ID: 7942622
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Delta Neutrophil Index Is Associated with Vasculitis Activity and Risk of Relapse in ANCA-Associated Vasculitis.
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Yonsei Med J; 2018 May; 59(3):397-405. PubMed ID: 29611402
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk factors of peritonitis during early peritoneal dialysis in patients with ANCA-associated systemic vasculitis
.
    Liu G; Chen J
    Clin Nephrol; 2018 Jul; 90(1):34-39. PubMed ID: 29465037
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Monitoring of endothelial leucocyte adhesion molecule-1 in anti-neutrophil-cytoplasmic-antibody-positive vasculitis.
    Yaqoob M; West DC; McDicken I; Bell GM
    Am J Nephrol; 1996; 16(2):106-13. PubMed ID: 8919225
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy.
    Lockwood CM
    Clin Exp Immunol; 1996 May; 104 Suppl 1():77-82. PubMed ID: 8625549
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
    PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression.
    de Joode AA; Sanders JS; Smid WM; Stegeman CA
    J Clin Apher; 2014 Oct; 29(5):266-72. PubMed ID: 24497412
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis.
    Neumann I; Kain R; Regele H; Soleiman A; Kandutsch S; Meisl FT
    Nephrol Dial Transplant; 2005 Jan; 20(1):96-104. PubMed ID: 15546891
    [TBL] [Abstract][Full Text] [Related]  

  • 77. No association between neutrophil FcgammaRIIa allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis.
    Tse WY; Abadeh S; McTiernan A; Jefferis R; Savage CO; Adu D
    Clin Exp Immunol; 1999 Jul; 117(1):198-205. PubMed ID: 10403936
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of cyclophosphamide on the prognosis of Japanese patients with renal vasculitis associated with anti-neutrophil cytoplasmic antibody-positive microscopic polyangiitis.
    Iwabuchi M; Nakaya I; Tsuchiya Y; Shibagaki Y; Yamaguchi T; Fukuhara S; Oe Y; Sakuma T; Sato T; Taguma Y; Soma J
    Clin Exp Nephrol; 2016 Oct; 20(5):712-719. PubMed ID: 26590052
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
    Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
    Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
    Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
    Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.